Cybozu Garoon up to 4.2.6 Access Restriction cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.5 | $0-$5k | 0.00 |
Summary
A vulnerability was found in Cybozu Garoon up to 4.2.6. It has been declared as critical. Affected by this vulnerability is an unknown functionality of the component Access Restriction. Executing a manipulation can lead to cross site scripting. This vulnerability appears as CVE-2018-0532. The attack may be performed from remote. There is no available exploit.
Details
A vulnerability has been found in Cybozu Garoon up to 4.2.6 (Groupware Software) and classified as critical. This vulnerability affects some unknown processing of the component Access Restriction. The manipulation with an unknown input leads to a cross site scripting vulnerability. The CWE definition for the vulnerability is CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. As an impact it is known to affect confidentiality, integrity, and availability. CVE summarizes:
Cybozu Garoon 3.0.0 to 4.2.6 allows remote authenticated attackers to bypass access restriction to alter setting data of the Standard database via unspecified vectors.
The bug was discovered 04/09/2018. The weakness was presented 04/16/2018 (Website). The advisory is shared for download at jvn.jp. This vulnerability was named CVE-2018-0532 since 11/27/2017. The attack can be initiated remotely. Required for exploitation is a single authentication. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1059.007.
The vulnerability was handled as a non-public zero-day exploit for at least 7 days. During that time the estimated underground price was around $0-$5k.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
See VDB-116246, VDB-116247, VDB-116249 and VDB-116250 for similar entries. VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://cybozu-global.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.5VulDB Meta Temp Score: 4.5
VulDB Base Score: 6.3
VulDB Temp Score: 6.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 2.7
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
11/27/2017 🔍04/09/2018 🔍
04/16/2018 🔍
04/16/2018 🔍
04/16/2018 🔍
01/25/2020 🔍
Sources
Vendor: cybozu-global.comAdvisory: jvn.jp
Status: Not defined
Confirmation: 🔍
CVE: CVE-2018-0532 (🔍)
GCVE (CVE): GCVE-0-2018-0532
GCVE (VulDB): GCVE-100-116248
See also: 🔍
Entry
Created: 04/16/2018 22:08Updated: 01/25/2020 11:14
Changes: 04/16/2018 22:08 (58), 01/25/2020 11:14 (2)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.